{"filing":{"accession_number":"0001213900-26-090472","cik":"0001828318","ticker":"ENVX","company_name":"Enovix Corp","form":"8-K","filing_date":"2026-08-17","report_date":"2026-08-13","primary_document":"ea0302318-8k_enovix.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1828318/000121390026090472/ea0302318-8k_enovix.htm"},"events":[{"id":28072,"run_id":25656,"accession_number":"0001213900-26-090472","anchor_item_number":"5.02","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.75,"summary":"Dr. Raj Talluri resigned as President, Chief Executive Officer, and director of Enovix Corp effective August 13, 2026, to pursue another opportunity. The filing discloses a leadership transition with the appointment of Ryan Benton as interim CEO and T.J. Rodgers as executive chairman.","company_name":"Enovix Corp","ticker":"ENVX","filing_date":"2026-08-17","form":"8-K","submitted_at":null,"items":[{"id":29871,"accession_number":"0001213900-26-090472","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"Dr. Raj Talluri resigned as President, Chief Executive Officer, and director on August 13, 2026, to pursue another opportunity. While the filing also discloses the appointment of an interim CEO (Ryan Benton) and executive chairman (T.J. Rodgers), the primary and most salient event is the departure of the sitting CEO. The resignation is material as it represents a significant leadership change at the company level.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-17T11:56:02.230070+00:00","company_name":"","ticker":null,"filing_date":""},{"id":29872,"accession_number":"0001213900-26-090472","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"The Item 7.01 disclosure references a leadership transition described in Item 5.02, and the attached press release announces that CEO Raj Talluri has resigned effective August 13, 2026. While the filing also discloses the appointment of Ryan Benton as interim CEO and T.J. Rodgers as executive chairman, the principal event disclosed in this Item 7.01 is the CEO departure. The departure of a sitting CEO is material to investors and affects the total mix of information about the registrant's governance and leadership continuity.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-17T11:56:02.230070+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":29871,"accession_number":"0001213900-26-090472","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"Dr. Raj Talluri resigned as President, Chief Executive Officer, and director on August 13, 2026, to pursue another opportunity. While the filing also discloses the appointment of an interim CEO (Ryan Benton) and executive chairman (T.J. Rodgers), the primary and most salient event is the departure of the sitting CEO. The resignation is material as it represents a significant leadership change at the company level.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-17T11:56:02.230070+00:00","company_name":"Enovix Corp","ticker":"ENVX","filing_date":"2026-08-17"},{"id":29872,"accession_number":"0001213900-26-090472","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"The Item 7.01 disclosure references a leadership transition described in Item 5.02, and the attached press release announces that CEO Raj Talluri has resigned effective August 13, 2026. While the filing also discloses the appointment of Ryan Benton as interim CEO and T.J. Rodgers as executive chairman, the principal event disclosed in this Item 7.01 is the CEO departure. The departure of a sitting CEO is material to investors and affects the total mix of information about the registrant's governance and leadership continuity.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-17T11:56:02.230070+00:00","company_name":"Enovix Corp","ticker":"ENVX","filing_date":"2026-08-17"}]}